Related Experiment Video

Updated: Aug 14, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

p16(Ink4a) inhibits histologic progression and angiogenic signaling in min colon tumors

Steven L Gibson1, Amelie Boquoi, Tina Chen

  • 1Department of Medicine, Cell and Molecular Biology Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6140, USA.

Cancer Biology & Therapy
|December 3, 2005
PubMed

Insights

The Ink4a/Arf tumor suppressor p16 (p16) restrains colon tumor progression by inhibiting vascular endothelial growth factor (VEGF) signaling, thereby limiting tumor growth and vascularity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Ink4a/Arf tumor suppressor locus is frequently inactivated in human cancers.
  • The roles of its products, p16(Ink4a) (p16) and Arf, in tumor biology remain incompletely understood.
  • Promoter methylation of p16 and Arf suggests functional importance in colon carcinomas.

Purpose of the Study:

  • To investigate the specific roles of p16 and Arf in the progression of colon tumors.
  • To determine the impact of p16 and Arf deficiencies on tumor growth, vascularity, and associated molecular pathways.
  • To elucidate the mechanism by which p16 influences colon tumor development.

Main Methods:

  • Analysis of Min colon tumors (N=215) in mice with selective deficiencies in p16 or Arf.
  • Histological examination for necrosis, apoptosis, and red blood cell density.
  • Biochemical assays to measure vascular endothelial cell growth factor (VEGF) levels.
  • In vitro studies of exogenous p16 expression in human colon tumor cells.

Main Results:

  • Absence of Arf did not significantly affect tumor formation.
  • Mice lacking p16 exhibited larger, redder tumors with increased necrosis and decreased apoptosis.
  • Tumors from p16-deficient mice showed higher red blood cell density and elevated VEGF levels.
  • Exogenous p16 expression suppressed VEGF production in human colon tumor cells.

Conclusions:

  • p16, but not Arf, plays a significant role in constraining colon tumor progression.
  • p16 inhibits colon tumor growth and vascularity, partly by suppressing VEGF-mediated angiogenic signaling.
  • These findings highlight p16 as a critical suppressor of angiogenesis in colon cancer.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...